ReviewCommunications medicine2025
A comprehensive overview of the burden, prevention, and therapeutic aspects of arboviral diseases in India.
Review in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Dengue and Chikungunya Seroprevalence in an Urban Low-Income Cohort in Delhi: A Cross-Sectional and Nested Longitudinal Study.Tropical medicine and infectious disease · 2026Article
- Eugenol-Derived Piperazine Mannich Bases as Selective Inhibitors of Mayaro Virus: In Vitro Antiviral Evaluation and Mechanistic Insights.Journal of medical virology · 2026Article
- The Burden of Chikungunya in India: An Overview of Clinical, Epidemiological, and Public Health Challenges.Cureus · 2026Review
- Breaking down barriers in Zika virus research: progressing immune pathogenesis research, international cooperation, and data sharing for preparedness.Journal of neurovirology · 2026Article
- Article
- Antibody landscapes of arboviral exposure across China revealed by high-throughput seroprofiling from a peptide epitope library.Infectious diseases of poverty · 2026Article
- External quality assurance of molecular serotype detection of dengue virus RNA among virus research and diagnostic laboratories in India.Frontiers in cellular and infection microbiology · 2026Article
- Knowledge, Attitudes, and Practices Regarding Arboviruses at a Human-Wildlife Interface: A Cross-Sectional Study in and Around Mole National Park, Ghana.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Outbreaks of arboviruses have become one of the major and consistent health burdens in India. With no effective vaccines or antivirals, it is challenging to control the exponential increase in cases of arboviral diseases. Accurate assessment of cases, timely and accurate diagnosis, treatment, tracking fatalities, surveillance of vectors, adopting integrated vector management policies, real-time genomic surveillance, and relating these to symptoms and tracking transmission are essential for keeping the emergence of arboviruses in check. This comprehensive review explores current literature and potential curative perspectives, focusing on major arboviruses, including dengue, chikungunya, Japanese encephalitis, Zika, Kyasanur forest disease, and Crimean-Congo haemorrhagic fever, and advancements in diagnosis, treatment protocols, supportive care, and the development of preventive measures. We aim to provide a thorough understanding of their epidemiology and impact in India, while identifying research and policy gaps that will enable policymakers to design effective strategies for managing the impact of arboviral diseases.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.